Therapeutic Potential of HDPs as Immunomodulatory Agents

Håvard Jenssen, Robert E.W. Hancock

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

    Resumé

    One of the most significant advances in medical history is the discovery and development of antibiotics, which in the middle of last century was flourishing and appeared to be the ultimate solution to the treatment of life-threatening human bacterial diseases. However, lately there has been a huge decline in the rate of discovery of new antimicrobial intervention strategies in parallel with an increasing incidence of multidrug-resistant pathogens; if these circumstances do not change we will continue to approach the end of the antibiotic era. Facing this dark future, scientists are considering new strategies for intervention tailored around the appropriate (selective) stimulation of the host’s immune system, and particularly rapid acting innate immunity, as an alternative to direct targeting of microbial pathogens. One recent player in such an immunomodulatory strategy is the naturally occurring host defence peptides (HDP) and their synthetic innate defence regulator (IDR) analogues. In this chapter, we will discuss the potential therapeutic use of HDPs and IDRs as immunomodulatory agents.
    OriginalsprogEngelsk
    TidsskriftMethods in Molecular Biology
    Vol/bind618
    Sider (fra-til)329-347
    ISSN1064-3745
    DOI
    StatusUdgivet - 2010

    Citer dette

    @article{58113ce52fa740d28174ef41c7f49fea,
    title = "Therapeutic Potential of HDPs as Immunomodulatory Agents",
    abstract = "One of the most significant advances in medical history is the discovery and development of antibiotics, which in the middle of last century was flourishing and appeared to be the ultimate solution to the treatment of life-threatening human bacterial diseases. However, lately there has been a huge decline in the rate of discovery of new antimicrobial intervention strategies in parallel with an increasing incidence of multidrug-resistant pathogens; if these circumstances do not change we will continue to approach the end of the antibiotic era. Facing this dark future, scientists are considering new strategies for intervention tailored around the appropriate (selective) stimulation of the host’s immune system, and particularly rapid acting innate immunity, as an alternative to direct targeting of microbial pathogens. One recent player in such an immunomodulatory strategy is the naturally occurring host defence peptides (HDP) and their synthetic innate defence regulator (IDR) analogues. In this chapter, we will discuss the potential therapeutic use of HDPs and IDRs as immunomodulatory agents.",
    author = "H{\aa}vard Jenssen and Hancock, {Robert E.W.}",
    year = "2010",
    doi = "10.1007/978-1-60761-594-1_20",
    language = "English",
    volume = "618",
    pages = "329--347",
    journal = "Methods in Molecular Biology",
    issn = "1064-3745",
    publisher = "Humana Press",

    }

    Therapeutic Potential of HDPs as Immunomodulatory Agents. / Jenssen, Håvard; Hancock, Robert E.W. .

    I: Methods in Molecular Biology, Bind 618, 2010, s. 329-347 .

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

    TY - JOUR

    T1 - Therapeutic Potential of HDPs as Immunomodulatory Agents

    AU - Jenssen, Håvard

    AU - Hancock, Robert E.W.

    PY - 2010

    Y1 - 2010

    N2 - One of the most significant advances in medical history is the discovery and development of antibiotics, which in the middle of last century was flourishing and appeared to be the ultimate solution to the treatment of life-threatening human bacterial diseases. However, lately there has been a huge decline in the rate of discovery of new antimicrobial intervention strategies in parallel with an increasing incidence of multidrug-resistant pathogens; if these circumstances do not change we will continue to approach the end of the antibiotic era. Facing this dark future, scientists are considering new strategies for intervention tailored around the appropriate (selective) stimulation of the host’s immune system, and particularly rapid acting innate immunity, as an alternative to direct targeting of microbial pathogens. One recent player in such an immunomodulatory strategy is the naturally occurring host defence peptides (HDP) and their synthetic innate defence regulator (IDR) analogues. In this chapter, we will discuss the potential therapeutic use of HDPs and IDRs as immunomodulatory agents.

    AB - One of the most significant advances in medical history is the discovery and development of antibiotics, which in the middle of last century was flourishing and appeared to be the ultimate solution to the treatment of life-threatening human bacterial diseases. However, lately there has been a huge decline in the rate of discovery of new antimicrobial intervention strategies in parallel with an increasing incidence of multidrug-resistant pathogens; if these circumstances do not change we will continue to approach the end of the antibiotic era. Facing this dark future, scientists are considering new strategies for intervention tailored around the appropriate (selective) stimulation of the host’s immune system, and particularly rapid acting innate immunity, as an alternative to direct targeting of microbial pathogens. One recent player in such an immunomodulatory strategy is the naturally occurring host defence peptides (HDP) and their synthetic innate defence regulator (IDR) analogues. In this chapter, we will discuss the potential therapeutic use of HDPs and IDRs as immunomodulatory agents.

    U2 - 10.1007/978-1-60761-594-1_20

    DO - 10.1007/978-1-60761-594-1_20

    M3 - Review

    VL - 618

    SP - 329

    EP - 347

    JO - Methods in Molecular Biology

    JF - Methods in Molecular Biology

    SN - 1064-3745

    ER -